Lilly (Eli) management check

LLY · Health Care · Pharmaceuticals · CEO David A Ricks

Filings as of

84
Management score, ranked 35th of 487 · 2nd of 60 in Health Care5 good · 1 to watch · 0 flaggedStrongest: owner returns · Weakest: dilution · Best and worst run in Health Care →

The seven checks

  • Good

    Have owners done well?

    Beat its chosen peersOwners$671Peers$154

    What $100 became since fiscal 2021

    100100th
    Detail

    $100 invested at the start of fiscal 2021 grew to $671, against $154 for the peer group the company picked itself.

  • Watch

    Does pay follow performance?

    Pay only loosely tracked returns20212025

    Pay actually paid $100 value, each on its own scale

    5315th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.07 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Good

    What does the CEO cost owners?

    0.2% of net income

    $36.7m pay · $20.6bn net income, FY2025

    0.1%1%3%10%
    100100th
    Detail

    $36.7m of reported pay in fiscal 2025, against $20.6bn of net income.

  • n/a

    Do they own the stock?

    No recent CEO filing
    ——

    Light activity: no buys, $25.8m sold in six months. 5 of 5 sales ran on pre-arranged 10b5-1 plans.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 912m2025 · 899m

    Diluted shares −0.2% a year; flagged above +2%

    0%10%20%

    Stock pay 1.0% of revenue

    5339th
    Detail

    Diluted shares changed -0.2% a year over the last three fiscal years. Stock-based pay was 1.0% of revenue in the latest year.

  • Good

    Is leadership stable?

    6 leadership filings in 3 years

    6 filings under 8-K 5.02 in 3 years

    0101420+

    CEO: Mr. Ricks

    9575th
    Detail

    CEO in the pay table: Mr. Ricks. 6 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2022

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2022.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed March 20, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$60.4m$120.9m$10020212022202320242025$671$154

Pay tied most to adjusted non-GAAP EPS

Other key measuresAdjusted non-GAAP EPSTotal Shareholder ReturnRevenue

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Mr. Ricks$36.7m$75.2m$10.9m$671$154$20.6bn
2024—$29.2m$80.6m$6.1m$478$123$10.6bn
2023—$26.6m$120.9m$7.8m$359$118$5.2bn
2022—$21.4m$64.1m$5.8m$223$125$6.2bn
2021—$21.5m$75.7m$4.7m$166$117$5.6bn

Insiders and the CEO's stakeQuiet

President, Chair, and CEO
David A Ricks
Shares held
555,278.097
Latest Form 4
Nov 3, 2026

Light activity: no buys, $25.8m sold in six months. 5 of 5 sales ran on pre-arranged 10b5-1 plans.

Open-market trades by officers and directors since May 21, 2026.

  • SoldAnat HakimEVP, GC & Secretary · 10b5-1 plan$13.0mNov 2, 2026
  • SoldPatrik JonssonEVP & President, LLY Int'l · 10b5-1 plan$7.6mAug 17, 2026
  • SoldIlya YuffaEVP&Pres, LLY USA&Global Capab · 10b5-1 plan$2.9mJun 10, 2026
  • SoldDonald A ZakrowskiSVP, Finance, & CAO · 10b5-1 plan$2.4mAug 10, 2026

Leadership and governance on file

20222023202420252026Leadership 8Votes 5
All 8 filings

Latest shareholder vote results: May 7, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $30.9bn returned to owners in buybacks and dividends, 64% of net income, and $2.6bn of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$10.3bn$20.6bn20212022202320242025Shares912m905m903m904m899m
Show the figures
Fiscal year20212022202320242025
Revenue$28.3bn$28.5bn$34.1bn$45.0bn$65.2bn
Net income$5.6bn$6.2bn$5.2bn$10.6bn$20.6bn
Stock-based pay$342.8m$371.1m$629.0m$646.0m$626.0m
Buybacks$1.3bn$1.5bn$750.0m$2.5bn$4.1bn
Dividends$3.1bn$3.5bn$4.1bn$4.7bn$5.4bn
Diluted shares912m905m903m904m899m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.